{"nct_id":"NCT01470131","title":"A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma","status":"TERMINATED","status_verified_date":"2018-12","start_date":"2011-05","start_date_type":"ACTUAL","primary_completion_date":"2017-01-04","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TXMD"]}